NCT00538954

Brief Summary

Factors which delay recovery following uncomplicated abdominal surgery include uncontrolled pain, intolerance of diet and poor mobility. Enhanced recovery after Surgery (ERAS) programmes are perioperative care pathways that address systematically these issues (i.e. improved dynamic pain relief, optimised nutritional care and enforced mobilisation) to promote a faster recovery and a shorter stay. The key treatments that improve outcome within an ERAS programme are not known. Moreover there are few acceptable, objective endpoints to assess key outcome variables such as return of GI function. This randomised trial will assess the potential synergy between early recovery of GI function (laxation) and early postoperative oral nutritional support(with associated preoperative preconditioning using carbohydrate/fluid loading). The main overall outcome targets being improved recovery of gastrointestinal function, postoperative nutritional status and physical function. It will validate the use of a novel, objective technique to measure gastric motility (surrogate for GI function). Such refinement of ERAS should result in shorter hospital stay and better use of limited health care resource.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2006

Typical duration for not_applicable

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2006

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

October 2, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 3, 2007

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2008

Completed
Last Updated

November 5, 2010

Status Verified

October 1, 2007

First QC Date

October 2, 2007

Last Update Submit

November 4, 2010

Conditions

Keywords

Perioperativerecoverynutritionenhancedlaxative

Outcome Measures

Primary Outcomes (1)

  • Recovery of gastrointestinal function: Time to pass flatus/stool (hours following the end of surgery)

    Number of hours post surgery

Secondary Outcomes (3)

  • t ½ Gastric emptying time on the morning of post-operative day 3

    Postoperative day 3

  • Length of hospital stay: nights spent in hospital post-op

    Until discharge

  • Patient activity level: measured by activPAL® activity meter

    postoperative day 2 - 7 and day 30 - 37

Study Arms (4)

1

ACTIVE COMPARATOR

Follow a standard Enhanced Recovery After Surgery protocol

Other: Standard ERAS group

2

EXPERIMENTAL

Follow a standard Enhanced Recovery After Surgery protocol and will receive 1 g of Magnesium Oxide laxative twice daily from the day after surgery until discharge

Drug: Post operative laxation (Magnesium Oxide)

3

EXPERIMENTAL

Follow a standard Enhanced Recovery After Surgery protocol and will receive preconditioning with carbohydrate and fluid loading prior to surgery (800ml of Nutricia Preop the evening before surgery and 400 the morning of surgery 2 hours prior to anaesthesia) and postoperative nutritional supplements (200 ml Nutricia Fortisip twice daily) after surgery for 30 days

Dietary Supplement: Preoperative metabolic conditioning postoperative nutritional supplementation

4

EXPERIMENTAL

Follow a standard Enhanced Recovery After Surgery protocol and will receive preconditioning with carbohydrate and fluid loading prior to surgery (800ml of Nutricia Preop the evening before surgery and 400 the morning of surgery 2 hours prior to anaesthesia) and postoperative nutritional supplements (200 ml Nutricia Fortisip twice daily) after surgery for 30 days and will receive postoperative laxative in the form of 20 ml of Magnesium Oxide twice daily form the day after surgery until discharge

Drug: Post operative laxation (Magnesium Oxide)Dietary Supplement: Preoperative metabolic conditioning postoperative nutritional supplementation

Interventions

20 ml of Magnesium Oxide twice daily from the day after surgery until discharge

24

Nutricia PreOP drinks 800 ml between 8-10 pm the evening before surgery Nutricia PreOP drinks 400 ml completed 2 hours before anaesthesia on the morning of surgery Nutricia Fortisip drinks 2 x 200 ml drinks from the day after surgery until day 30

34

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing hepatic resection for benign or malignant conditions
  • Able to understand the nature of the study and what will be required of them.
  • Men and non-pregnant, non-lactating women
  • BMI 18 - 30

You may not qualify if:

  • Inability to give written, informed consent
  • Patients with dementia or neurological impairment
  • Patients with pre-existing condition limiting mobility
  • Planned bile duct excision
  • Repeat or staged procedures
  • Central extended resections
  • Underlying cirrhotic liver disease
  • Jaundice (Bilirubin \> 50 μmol/L)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University Hospital Maastricht

Maastricht, Netherlands

Location

Edinburgh Royal Infirmary

Edinburgh, EH16 4SA, United Kingdom

Location

Related Publications (1)

  • Hendry PO, van Dam RM, Bukkems SF, McKeown DW, Parks RW, Preston T, Dejong CH, Garden OJ, Fearon KC; Enhanced Recovery After Surgery (ERAS) Group. Randomized clinical trial of laxatives and oral nutritional supplements within an enhanced recovery after surgery protocol following liver resection. Br J Surg. 2010 Aug;97(8):1198-206. doi: 10.1002/bjs.7120.

MeSH Terms

Interventions

Magnesium Oxide

Intervention Hierarchy (Ancestors)

Magnesium CompoundsInorganic ChemicalsOxidesOxygen Compounds

Study Officials

  • Paul Hendry, MBChB

    University of Edinburgh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
FACTORIAL
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 2, 2007

First Posted

October 3, 2007

Study Start

August 1, 2006

Study Completion

August 1, 2008

Last Updated

November 5, 2010

Record last verified: 2007-10

Locations